-Reuters Cited Spokesperson
Adial Pharmaceuticals Shares Spike Higher; Co Says Plans To Enter Genetic Testing Market Following Allowance Of U.S. Patent For Genetic Diagnostic Test
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL, ADILW)))), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced plans